| Is one of the
stocks more liquid than the other? |
| The Class A Common
Stock is the more liquid of the two classes; however, both stocks trade very
closely to each other in dollar price per share. |
| |
| Does KV
Pharmaceutical have a direct purchase plan? |
| No. |
| |
| Does KV
Pharmaceutical Company pay a dividend? |
| The company does not
anticipate paying dividends in the near term on its Class A and Class B Common
Stock. Earnings will be reinvested in drug delivery development, research, the
development and acquisition of products, and the expansion of the business. |
| |
| When is the
company's fiscal year-end? |
| The company has a
fiscal year-end of March 31st. |
| |
| When will the
company file the next financial earnings report? |
| Historically, the
company has released its financial earnings report during November. |
| |
| How many
employees does the company have? |
| The company currently
has approximately 390 employees as of March 31, 2010. |
| |
| How many shares
are outstanding? |
As of March 31, 2008
the company has a combined 49.55 million shares outstanding:
Class A accounting for 37,475,279 million shares
Class B accounting for 12,077,270 million shares
|
| |
| Who is the
company's transfer agent? |
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
1-800-884-4225
web.queries@computershare.com |
| |
| Who is the
company contact for questions? |
Investor Relations Department
KV Pharmaceutical Company
One Corporate Woods Drive
St. Louis, MO 63044
Phone: 314-645-6600
Fax: 314-646-3751
E-mail: investorrelations@kvpharmaceutical.com
|